Faculty of Medicine

Academic Members

Nuri Faruk Aykan

Nuri Faruk Aykan,  Prof.

Faculty Member

He was born on January 14, 1953 in Kahramanmaraş. He graduated from Kahramanmaraş High School in 1970 and Ankara University Faculty of Medicine in 1976 with first degree. He became Internal Medicine Specialist at the same faculty in 1981. In the same year, he worked on genetic manipulations at the University of Louis Pasteur in Strasbourg. He became Associate Professor in 1987, Medical Oncology Specialist at Istanbul University Oncology Institute in 1991 and Professor in 1995. He is a member of ASCO and certified ESMO. In March 2017, he left the Istanbul University Oncology Institute, where he worked for 29 years, and started to work in Istinye University Faculty of Medicine Bahçeşehir Liv Hospital. He served as a member of the Board of Medical Oncology Association and Oncology Group Association - Turkish Oncology Group. He is married with one child and has 121 publications in Turkish, English and French in various medical books and journals, and 109 papers presented at national and international congresses. 41 of his publications have been published in PubMed indexed journals. His publications have been cited in 3492 by February 2020 and his H-index: 16, i10-index: 22 (Source: www.googlescholar.com). His principal clinical research interests have been in gastrointestinal cancers. He has participated to some international studies such as PETACC-1, CPT-CMA 202, Aventis V-306, V-307, CRYSTAL, RADIANT-2, CORRECT, RILOMET, REGARD and MODUL. His another area of interest is theoretical biology, especially intercellular communication. He is in the editorial board of the World Journal of Gastrointestinal Oncology (2018), Turkish Journal of Cancer (2003) and Acta Oncologica (Turkish Edition) (2004). Prof. N. Faruk Aykan speaks English and French.

Main Areas: Tıbbi Onkoloji, 

2019 - Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients
ARTAÇ MEHMET,KORKMAZ LEVENT,COŞKUN HASAN ŞENOL,DANE FAYSAL,KARABULUT BÜLENT,KARAAĞAÇLI MUSTAFA,ÇABUK DEVRİM,KARABULUT SENEM,AYKAN NURİ FARUK,doruk hatice,AVCI NİLÜFER,turhal serdar. Journal of Gastrointestinal Cancer, 50(2), 214-220.
2018 - Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study
Korkmaz Levent,COŞKUN HASAN ŞENOL,DANE FAYSAL,KARABULUT BÜLENT,KARAAĞAÇ MUSTAFA,ÇABUK DEVRİM,KARABULUT SENEM,AYKAN NURİ FARUK,Doruk Hatice,AVCI NİLÜFER,Turhal Nazım Serdar,ARTAÇ MEHMET. Surgical Oncology, 27(3), 485-489.
2018 - Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study
KORKMAZ LEVENT,COŞKUN HASAN ŞENOL,DANE FAYSAL,KARABULUT BÜLENT,KARAAĞAÇLI MUSTAFA,ÇABUK DEVRİM,KARABULUT SENEM,AYKAN NURİ FARUK,doruk hatice,AVCI NİLÜFER,turhal serdar,ARTAÇ MEHMET. Surgical Oncology, 27(3), 485-489.
2018 - Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers
KAYTAN SAĞLAM ESRA,FAYDA EMRE MERDAN,AYKAN NURİ FARUK,BALIK EMRE,KİZİR AHMET,GÜLLÜOĞLU MİNE. Tumori Journal, 104(4), 266-272.
2017 - Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: a family report
ENGİN GÜLGÜN,ERASLAN SERPIL,KAYSERİLİ KARABEY HÜLYA,KAPRAN YERSU,AKMAN HALUK,AKYÜZ ALİ,AYKAN NURİ FARUK. World Journal of Radiology, 9(9), 365-370.
2017 - CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIALBIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA
AFŞAR ÇİĞDEM USUL,KARABULUT MEHMET,KARABULUT SENEM,ALİŞ HALİL,BİNBOĞA SİNAN,BİLGİN ELİF,AYKAN NURİ FARUK. ACTA MEDİCA MEDİTERRANEA,
2017 - Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer
KARABULUT MEHMET,Afsar Cigdem Usul,Alıs Halil,Oran Ebru,Karabulut Senem,Akarsu Cevher,Sahbaz Nuri Alper,Gümüsoglu Alpen Yahya,BİLGİN ELİF,AYKAN NURİ FARUK. Molecular and Clinical Oncology, 7(5), 787-797.
2017 - CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA
Afsar Cigdem Usul,KARABULUT MEHMET,Karabulut Senem,Alis Halil,Binboga Sinan,BİLGİN ELİF,AYKAN NURİ FARUK. ACTA MEDICA MEDITERRANEA, 33(3), 501-507.
2017 - Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.
Gürdal Necla,FAYDA EMRE MERDAN,Alishev Nejat,BAKIR BARIŞ,Taştekin Didem,AYKAN NURİ FARUK,GEZER UĞUR,BALIK EMRE,KAYTAN SAĞLAM ESRA,ORAL ETHEM NEZİH,GÜLLÜOĞLU MİNE,KİZİR AHMET. Tumori,
2016 - Clinical significance of serum interleukin-17 levels in colorectal cancer patients
KARABULUT SENEM,USUL AFŞAR ÇİĞDEM,KARABULUT MEHMET,KILIÇ LEYLA,ALIŞ HALİL,OSMAN KONES,BİLGİN ELİF,AYKAN NURİ FARUK. Journal of BUON, 21(5), 1137-1145.
2016 - Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study
ARTAÇ MEHMET,COŞKUN HASAN ŞENOL,DANE FAYSAL,KARABULUT BÜLENT,KORKMAZ LEVENT,KARAAĞAÇ MUSTAFA,ÇABUK DEVRİM,KARABULUT SENEM,AYKAN NURİ FARUK,DORUK HATİCE,AVCI NİLÜFER,TURHAL NAZIM SERDAR. Journal of Gastrointestinal Cancer, 47(3), 264-272.
2016 - Red meat and colorectal cancer
AYKAN NURİ FARUK. Oncology Reviews, 9(1), 38-44.
2015 - Serum neural precursor cell expressed developmentally down regulated 9 NEDD9 level may have a prognostic role in patients with gastric cancer
MEHMET KARABULUT,AYKAN NURİ FARUK. Biomedicine & Pharmacotherapy, 73(), 140-146.
2015 - Serum nectin 2 levels are diagnostic and prognostic in patients with colorectal carcinoma
AYKAN NURİ FARUK. Clinical and Translational Oncology,
2015 - Evaluation of Serum Interleukin 17 IL 17 Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma
AYKAN NURİ FARUK. Journal of Gastrointestinal Cancer,
2015 - Clinical significance of serum claudin 1 and claudin 7 levels in patients with colorectal cancer
AYKAN NURİ FARUK. Molecular and Clinical Oncology,
2015 - Red meat subtypes and colorectal cancer risk
AYKAN NURİ FARUK. International Journal of Cance, 137(), 1788-.
2015 - Epidemiology of colorectal cancer in Turkey A cross sectional disease registry study A Turkish Oncology Group trial
AYKAN NURİ FARUK. Turkish Journal of Gastroenterology, 26(), 145-153.
2014 - Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients
TAŞTEKİN DİDEM,KARGIN SÜLEYMAN,KARABULUT MEHMET,yaldız naile,TAMBAŞ MAKBULE,GÜRDAL NECLA,AYKAN NURİ FARUK. Tumor Biology, 35(12), 11871-11877.
2014 - Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
HAS ŞİMŞEK DUYGU,KUYUMCU SERKAN,TÜRKMEN CÜNEYT,ŞANLI YASEMİN,AYKAN NURİ FARUK,ÜNAL SEHER NİLGÜN,ADALET IŞIK. Journal of Nuclear Medicine, 55(11), 1811-1817.
2013 - Effect of increased body mass index BMI on time to tumour progression TTP in unresectable metastatic colorectal cancer mCRC patients treated with bevacizumab based therapy
AYKAN NURİ FARUK,YILDIZ İBRAHİM,ŞEN FATMA,KILIÇ LEYLA,KESKİN SERKAN. Medical Oncology, 30(3), 679-684.
2013 - Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection can we avoid radiotherapy in a subgroup of patients
KILIÇ LEYLA,ORDU ÇETİN,EKENEL MELTEM,YILDIZ İBRAHİM,KESKİN SERKAN,AYKAN NURİ FARUK. Medical Oncology, 30(3), 660-.
2011 - Prognostic significance of the metastatic lymph node ratio for survival in colon cancer
ŞAKAR BURAK,AYKAN NURİ FARUK. Journal of BUON, 16(3), 478-485.
2011 - A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma
SAĞLAM SEZER,AYKAN NURİ FARUK,ŞAKAR BURAK,GÜLLÜOĞLU MİNE,BALIK EMRE,KARANLIK HASAN. Journal of Gastrointestinal Oncology, 2(1), 19-26.
2009 - Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients
SALEPCİ TAFLAN,YAZICI HÜLYA,DANE FAYSAL,TOPUZ ERKAN,DALAY NEJAT,AYKAN NURİ FARUK. J BUON, 14(3), 495-499.
2008 - The role of UFT in advanced gastric cancer
AYKAN NURİ FARUK,EFRAIM IDELEVICH. Annals of Oncology, 19(6), 1045-1052.
2006 - Penile metastasis of cutaneous malignant melanoma a true hematogenous spread Case report and review of the literature
SIDIKA KURUL,AYKAN NURİ FARUK,TAŞ FARUK. Melanoma Research, 16(3), 259-261.
2004 - Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer
ŞAKAR BURAK,KARAGÖL HAKAN,GÜMÜŞ MAHMUT,BAŞARAN MERT,KAYTAN SAĞLAM ESRA,ARGON ANDAÇ,ZEKİ ÜSTÜNER,SEVİL BAVBEK,BUĞRA DURSUN,AYKAN NURİ FARUK. American Journal of Clinical Oncology, 27(2), 205-209.
2001 - Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.
TAŞ FARUK,AYKAN NURİ FARUK,AYDINER ADNAN,YASASEVER VILDAN,TOPUZ ERKAN. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 24(2), 148-149.
2001 - Prognostic Factors in Pancreatic Carcinoma Serum LDH Levels Predict Survival in Metastatic Disease
TAŞ FARUK,AYKAN NURİ FARUK,ALICI SÜLEYMAN,KAYTAN SAĞLAM ESRA,AYDINER ADNAN,ERKAN TOPUZ. American Journal of Clinical Oncology, 24(6), 547-550.
2000 - The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival
TAŞ FARUK,AYKAN NURİ FARUK,AYDINER ADNAN,UYGUN KAZIM,BAŞARAN MERT,HAKAN ÇAMLICA,ERKAN TOPUZ. American Journal of Clinical Oncology, 23(1), 53-57.
1998 - A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma.
İÇLİ FİKRİ,ÇELİK İSMAİL,AYKAN NURİ FARUK,ÜNER AYTUĞ,DEMİRKAZIK AHMET,ÖZET AHMET,ÖZGÜROĞLU MUSTAFA,TAŞ FARUK,AKBULUT HAKAN,FIRAT DİNÇER. CANCER, 83(12), 2475-2480.
Body-mass Index and Health
2019 - İngilizce, Bilimsel Kitap
ISBN: DOI: 10.5772/intechopen.78617
AYKAN NURİ FARUK,ARTAÇ MEHMET,ÖZATLI TAHSİN
Current Frontiers and Perspectives in Cell Biology
2019 - İngilizce, Bilimsel Kitap
ISBN: 978-953-51-0544-2
AYKAN NURİ FARUK
İleri evre mide kanserinde tedavi yaklaşımları
2018 - Türkçe, Bilimsel Kitap
ISBN: 978-975-9118-71-6
YALÇIN ŞUAYİB,ÇİÇİN İRFAN,AYKAN NURİ FARUK,MANDEL NİL KLER
İleri evre mide kanserinde tedavi yaklaşımları
2018 - Türkçe, Bilimsel Kitap
ISBN: 978-975-9118-71-6
YALÇIN ŞUAYİB,ÇİÇİN İRFAN,AYKAN NURİ FARUK,MANDEL NİL KLER
İLERİ EVRE MİDE KANSERİNDE TEDAVİ YAKLAŞIMLARI
2018 - Türkçe, Bilimsel Kitap
ISBN: 978-975-9118-71-6
YALÇIN ŞUAYİB,AYKAN NURİ FARUK,ÇİÇİN İRFAN,MANDEL NİL KLER
Sindirim Sistemi Kanserleri
1998 - Türkçe,
ISBN:
AYKAN FARUK
(1976), "Tıp Fakültesi mezuniyet birincilik ödülü", "Üniversite", "İSTANBUL ÜNİVERSİTESİ/ONKOLOJİ ENSTİTÜSÜ/KLİNİK ONKOLOJİ ANABİLİM DALI/", "PROFESÖR", "Alanında yurtiçi kamu kurum ve kuruluşlarından alınan ödül", "ANKARA ÜNİVERSİTESİ", Diğer